Trials / Completed
CompletedNCT02007187
Danhong Injection in the Treatment of Unstable Angina Pectoris
A Randomized, Double-blind, Multicenter, Parallel Controlled Clinical Trial of Danhong Injection in the Treatment of Unstable Angina Pectoris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of Danhong injection in the treatment of unstable angina pectoris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danhong injection | A kind of injection made from two kind of Chinese herbs: salvia miltiorrhiza and safflower |
| OTHER | Standard medical care | Standard medical care is in accordance with China Guideline for the diagnosis and treatment of unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI) (2007) issued by Chinese Society of Cardiology of Chinese Medical Association |
| DRUG | Placebo | 0.9% saline added into 250ml 0.9% saline by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2017-08-01
- Completion
- 2017-11-01
- First posted
- 2013-12-10
- Last updated
- 2017-12-02
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02007187. Inclusion in this directory is not an endorsement.